思连康蒙脱石散联用治疗小儿腹泻的疗效评价

摘要

目的：探讨评价思连康蒙脱石散联用治疗小儿腹泻的疗效。方法：选取70例1~3岁腹泻患儿，采取随机对照的方法，将其分为治疗组和对照组，治疗组30例，采用口服思连康蒙脱石散联用的治疗方法，思连康每人2粒/次，2次/d，蒙脱石散1次半包，3次/d。对照组单独使用两种药物其中一种，思连康20例（每人2粒/次，2次/d），蒙脱石散20例（每人1次半包，3次/d）。比较两组临床大便次数及性状的改变情况和疗效。结果：治疗组痊愈21例，好转8例，无效1例，总有效率达到96.6%；对照组痊愈18例，好转10例，无效12例，总有效率达到70.0%，两组有效率比较差异具有统计学意义（P<0.05），治疗组疗效优于对照组。结论：思连康蒙脱石散联用对治疗小儿腹泻具有更好的疗效。%Objective:To investigate treatment efficacy of tetravaccine associated with montmorillonite powder for diarrhea in children. Method:70 children with,one to three years old,were randomly divided into treatment group and control group. Treatment group(30 cases) were given oral tetravaccine montmorillonite powder associated with treatment,including 2 tetravaccine per person/1 time,2 times per day,and montmorillonite powder half a pack,3 times per day. The control group was treated with tetravaccine separate used one divided into tetravaccine 20 cases (two per person/times, 2 times per day),montmorillonite powder 20 cases (a half a pack of two drugs 3 times per day). To compare the clinical stool frequency,traits change and situation of the two groups. Result:In the treatment group,21 cases were cured,8 cases improved,and 1 case got no effect,the total efficiency was 96.6%.In the control group,18 cases were cured,10 cases improved,12 cases got no effect,the total efficiency was 70.0%. There were statistically significant in the two groups(P<0.05). The treatment group seemed better. Conclusion:Tetravaccine associated with montmorillonite powder has better efficacy for the treatment of diarrhea in children.